|
SLC25A13 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.118200E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.320850E-01 |
| Normal-vs-Stage2 |
3.230100E-02 |
| Normal-vs-Stage3 |
1.860770E-01 |
| Normal-vs-Stage4 |
4.988200E-02 |
| Stage1-vs-Stage2 |
3.956600E-03 |
| Stage1-vs-Stage3 |
8.810200E-01 |
| Stage1-vs-Stage4 |
3.238200E-01 |
| Stage2-vs-Stage3 |
4.963500E-03 |
| Stage2-vs-Stage4 |
1.660200E-03 |
| Stage3-vs-Stage4 |
4.778000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.209000E-01 |
| Normal-vs-AfricanAmerican |
6.271600E-01 |
| Normal-vs-Asian |
2.198000E-01 |
| Caucasian-vs-AfricanAmerican |
6.624600E-01 |
| Caucasian-vs-Asian |
9.064000E-01 |
| AfricanAmerican-vs-Asian |
6.055400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.930000E-02 |
| Normal-vs-Female |
5.872200E-01 |
| Male-vs-Female |
9.428200E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.408420E-01 |
| Normal-vs-Age(41-60Yrs) |
3.230400E-01 |
| Normal-vs-Age(61-80Yrs) |
6.869400E-01 |
| Normal-vs-Age(81-100Yrs) |
7.120100E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.517600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.565600E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.392000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.879970E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.778200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.307610E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.876600E-01 |
| Classical-VS-Follicular |
2.320100E-03 |
| Classical-VS-Other |
1.622180E-01 |
| Classical-VS-Normal |
1.498550E-01 |
| Tall-VS-Follicular |
1.321050E-03 |
| Tall-VS-Other |
2.228400E-01 |
| Tall-VS-Normal |
5.732000E-02 |
| Follicular-VS-Other |
3.142500E-03 |
| Follicular-VS-Normal |
7.915700E-02 |
| Other-VS-Normal |
2.213700E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.097200E-01 |
| Normal-vs-N1 |
6.225900E-02 |
| N0-vs-N1 |
5.978300E-02 |
|
|
